Emanuele Crocetti
Overview
Explore the profile of Emanuele Crocetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
2755
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crocetti E, Ravaioli A, Falcini F, Vattiato R, Mancini S, Baldacchini F, et al.
Eur J Cancer Prev
. 2025 Feb;
PMID: 39980466
Objective: The epidemiologic scenario of prostate cancer (PC) is changing rapidly. The present study updates to 2024 the estimates of PC in Italy, including incident and prevalent cases, deaths, and...
2.
Crocetti E, Zamagni F, Falcini F, Vattiato R, Baldacchini F, Balducci C, et al.
Ital J Dermatol Venerol
. 2025 Jan;
160(1):1-6.
PMID: 39841137
Background: The epidemiology of skin melanoma (SM) is rapidly changing. Therefore, we aimed at updating up to 2024 the Italian estimates on SM providing the number of incident and prevalent...
3.
Stanganelli I, Magi S, Bucchi L, Crocetti E, Mancini S, Vattiato R, et al.
Dermatol Reports
. 2024 Nov;
16(3):9919.
PMID: 39484362
The text discusses the role of general practitioners (GPs) in the prevention and early diagnosis of melanoma, a type of skin cancer. It highlights the need for GPs to be...
4.
Bucchi L, Giudici F, Toffolutti F, De Paoli A, Mancini S, Preti M, et al.
Eur J Surg Oncol
. 2024 Oct;
:108707.
PMID: 39467724
Objective: Five-year net survival and conditional survival from vulvar squamous cell carcinoma (VSCC) patients in Italy have shown no progress during the past three decades. This study aims to estimate...
5.
Zamagni F, Falcini F, Magi S, Bucchi L, Mancini S, Vattiato R, et al.
Dermatol Reports
. 2024 Sep;
16(3):9920.
PMID: 39290553
According to the National Oncological Plan 2023-2027 on the importance of multidisciplinary and interactive e-learning training, the Italian Melanoma Intergroup (IMI) has developed MelaMEd (Melanoma Multimedia Education), a national project...
6.
Bucchi L, Mancini S, Zamagni F, Crocetti E, Dal Maso L, Ferretti S, et al.
Tumori
. 2024 Jun;
110(4):264-272.
PMID: 38825831
Background: In Italy, the incidence of cutaneous malignant melanoma is two-fold higher in the north than in the south. This gradient might be associated with differences in incidence trends and...
7.
Dal Maso L, Toffolutti F, De Paoli A, Giudici F, Francisci S, Bucchi L, et al.
Int J Cancer
. 2024 Mar;
155(2):270-281.
PMID: 38520231
People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are increasing. This paper aimed to estimate the indicators of cancer cure and complete prevalence for Italian patients...
8.
Crocetti E, Ravaioli A, Falcini F, Vattiato R, Mancini S, Baldacchini F, et al.
Tumori
. 2024 Feb;
110(2):109-115.
PMID: 38372036
Introduction: This cross-sectional study was aimed at estimating the number of Italian incident cancer patients in 2020 eligible for, and respondent to, immune checkpoint inhibitors (ICI). Methods: The study is...
9.
Bucchi L, Mancini S, Crocetti E, Dal Maso L, Baldacchini F, Vattiato R, et al.
Ital J Dermatol Venerol
. 2023 Nov;
158(6):483-492.
PMID: 38015485
A recent research project using data from a total of 40 cancer registries has provided new epidemiologic insights into the results of efforts for melanoma control in Italy between the...
10.
Stoppa G, Nuvolone D, Petri D, Centi L, Nistico F, Crocetti E, et al.
PLoS One
. 2023 Nov;
18(11):e0293619.
PMID: 37910515
Background: The geothermal power plants for electricity production currently active in Italy are all located in Mt. Amiata area in the Tuscany region. A cross-sectional survey was conducted in the...